Retinopathy of prematurity (ROP) is an eye disease in some premature infants born before 31 weeks (a full-term pregnancy is about 37 to 42 weeks). It is a problem of the retina. The retina is a ...

and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and ...

Abstract: Retinopathy of Prematurity (ROP) is a severe disease that occurs in premature babies due to abnormal development of retinal vessels and can lead to permanent vision loss. Fundus images are ...

The low-dose form of Eylea is also approved to treat patients with retinopathy of prematurity (ROP), neovascular (wet) age-related macular degeneration (AMD), macular edema, and diabetic retinopathy.